Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Free Cash Flow (2016 - 2025)

Veracyte's Free Cash Flow history spans 14 years, with the latest figure at $56.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 175.58% year-over-year to $56.2 million; the TTM value through Dec 2025 reached $134.0 million, up 110.0%, while the annual FY2025 figure was $134.0 million, 110.0% up from the prior year.
  • Free Cash Flow for Q4 2025 was $56.2 million at Veracyte, up from $39.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $56.2 million in Q4 2025 and bottomed at -$41.8 million in Q1 2021.
  • The 5-year median for Free Cash Flow is $7.5 million (2021), against an average of $10.4 million.
  • The largest annual shift saw Free Cash Flow crashed 671.28% in 2021 before it surged 1411.6% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at $8.1 million in 2021, then soared by 103.1% to $16.4 million in 2022, then fell by 20.5% to $13.1 million in 2023, then soared by 56.13% to $20.4 million in 2024, then skyrocketed by 175.58% to $56.2 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Free Cash Flow are $56.2 million (Q4 2025), $39.4 million (Q3 2025), and $34.9 million (Q2 2025).